Boshoff Chris's Insider Trades & SAST Disclosures
Boshoff Chris's most recent trade in Pfizer Inc. was a trade of 495,765 Stock Appreciation Rights done . Disclosure was reported to the exchange on March 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Boshoff Chris.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer Inc. | Chris Boshoff | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 495,765 | 495,765 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Chris Boshoff | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 17,450 | 172,147 (0%) | 0% | 0 | Common Stock | |
| Pfizer Inc. | Chris Boshoff | President, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.10 per share. | 27 Feb 2025 | 8,909 | 163,238 (0%) | 0% | 26.1 | 232,525 | Common Stock |
| Pfizer Inc. | Chris Boshoff | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 9,687 | 159,972 (0%) | 0% | 0 | Common Stock | |
| Pfizer Inc. | Chris Boshoff | President, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.42 per share. | 26 Feb 2025 | 4,872 | 155,100 (0%) | 0% | 26.4 | 128,718 | Common Stock |
| Pfizer Inc. | Chris Boshoff | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.17 per share. | 22 Feb 2025 | 8,741 | 159,085 (0%) | 0% | 30.2 | 263,716 | Common Stock |
| Pfizer Inc. | Chris Boshoff | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 8,741 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Chris Boshoff | President, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.08 per share. | 22 Feb 2025 | 7,798 | 150,947 (0%) | 0% | 26.1 | 203,372 | Common Stock |
| Pfizer Inc. | Chris Boshoff | President, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.30 per share. | 22 Feb 2025 | 662 | 150,285 (0%) | 0% | 26.3 | 17,411 | Common Stock |
| Pfizer Inc. | Chris Boshoff | President, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.65 per share. | 22 Feb 2025 | 403 | 149,882 (0%) | 0% | 26.7 | 10,740 | Common Stock |
| Pfizer Inc. | Chris Boshoff | President, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.30 per share. | 22 Feb 2025 | 340 | 158,745 (0%) | 0% | 26.3 | 8,942 | Common Stock |
| Pfizer Inc. | Chris Boshoff | President, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.52 per share. | 31 Jan 2025 | 12,038 | 150,344 (0%) | 0% | 26.5 | 319,248 | Common Stock |
| Pfizer Inc. | Chris Boshoff | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 11,510 | 160,157 (0%) | 0% | 0 | Common Stock | |
| Pfizer Inc. | Chris Boshoff | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.04 per share. | 28 Feb 2024 | 4,150 | 156,007 (0%) | 0% | 27.0 | 112,216 | Common Stock |
| Pfizer Inc. | Chris Boshoff | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 161,160 | 161,160 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Boshoff Chris | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 142,400 | 142,400 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Boshoff Chris | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 15,455 | 154,844 (0%) | 0% | 0 | Common Stock | |
| Pfizer Inc. | Boshoff Chris | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 9,752 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Chris Boshoff | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2024 | 9,752 | 148,703 (0%) | 0% | 27.3 | 266,620 | Common Stock |
| Pfizer Inc. | Chris Boshoff | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.37 per share. | 23 Feb 2024 | 7,881 | 139,689 (0%) | 0% | 27.4 | 215,703 | Common Stock |
| Pfizer Inc. | Boshoff Chris | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 4,794 | 148,647 (0%) | 0% | 27.8 | 133,081 | Common Stock |
| Pfizer Inc. | Chris Boshoff | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 1,403 | 153,441 (0%) | 0% | 27.8 | 38,947 | Common Stock |
| Pfizer Inc. | Chris Boshoff | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 675 | 147,570 (0%) | 0% | 27.8 | 18,738 | Common Stock |
| Pfizer Inc. | Chris Boshoff | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 458 | 148,245 (0%) | 0% | 27.8 | 12,714 | Common Stock |
| Pfizer Inc. | Boshoff Chris | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 300 | 139,389 (0%) | 0% | 27.8 | 8,328 | Common Stock |
| Pfizer Inc. | Chris Boshoff | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 34,734 | 137,296 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges